Desq Long
Sign in

Company

BioNexus Gene Lab Corp

BGLC · CIK 0001737523

SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 16,129 shares; price not stated (see filing).

Reporting Person Low Jook Yuen · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000345 · filed 2026-08-14 · View filing →

SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 96,774 shares; price not stated (see filing).

Reporting Person Chong Set Fui · Officer Title Chief Financial Officer · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000346 · filed 2026-08-14 · View filing →

SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 32,258 shares; price not stated (see filing).

Reporting Person Bin Abdul Hamid Muhammad Azrul · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000347 · filed 2026-08-14 · View filing →

SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 32,258 shares; price not stated (see filing).

Reporting Person Yap Chee Keong · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000348 · filed 2026-08-14 · View filing →

SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 338,709 shares; price not stated (see filing).

Reporting Person Tan Lee Su-Leng · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000349 · filed 2026-08-14 · View filing →